uniQure N.V. Files Definitive Proxy Statement (DEF 14A)

TL;DR

<b>uniQure N.V. has filed its Definitive Proxy Statement (DEF 14A) detailing executive compensation and corporate governance matters.</b>

AI Summary

uniQure N.V. (QURE) filed a Proxy Statement (DEF 14A) with the SEC on April 24, 2024. uniQure N.V. filed a Definitive Proxy Statement (DEF 14A) on April 24, 2024. The filing covers the period ending June 18, 2024. The company's fiscal year ends on December 31. The filing includes data related to executive compensation for PEO and Non-PEO members for the years 2021, 2022, and 2023. Specific compensation components include stock awards, option awards, and equity award adjustments.

Why It Matters

For investors and stakeholders tracking uniQure N.V., this filing contains several important signals. This filing is crucial for shareholders to understand executive compensation structures and make informed voting decisions at the upcoming meeting. The detailed breakdown of stock and option awards provides insight into how the company incentivizes its leadership and aligns their interests with shareholder value.

Risk Assessment

Risk Level: low — uniQure N.V. shows low risk based on this filing. The filing is a routine proxy statement, providing standard disclosures without immediate financial or operational red flags.

Analyst Insight

Shareholders should review the executive compensation details and any proposed resolutions before the June 18, 2024 meeting.

Key Numbers

• 2024-04-24 — Filing Date (Date the DEF 14A was filed)
• 2024-06-18 — Period of Report (The period the proxy statement pertains to)
• 2023 — Compensation Year (Most recent full fiscal year for which compensation data is provided)
• 2022 — Compensation Year (Prior fiscal year for which compensation data is provided)
• 2021 — Compensation Year (Earlier fiscal year for which compensation data is provided)

Key Players & Entities

• uniQure N.V. (company) — Filer of the DEF 14A
• DEF 14A (filing) — Type of document filed
• 2024-04-24 (date) — Filing date
• 2024-06-18 (date) — Period of report
• 2023 (date) — Fiscal year for compensation data
• 2022 (date) — Fiscal year for compensation data
• 2021 (date) — Fiscal year for compensation data

FAQ

Industry Context

uniQure N.V. operates in the biotechnology sector, focusing on gene therapies.

Regulatory Implications

As a publicly traded company, uniQure N.V. is subject to SEC regulations regarding disclosures, including proxy statements.

What Investors Should Do

1. Review the executive compensation tables for PEO and Non-PEO members for 2023.
2. Examine the details of stock and option awards granted in 2023.
3. Understand any proposals or resolutions presented for shareholder vote.

Key Dates

• 2024-04-24: Filing of DEF 14A — Provides updated information on executive compensation and corporate governance.
• 2024-06-18: Period of Report End Date — Marks the end of the reporting period for the proxy statement's content.

Year-Over-Year Comparison

This is a DEF 14A filing, which is a standard annual disclosure for public companies, providing details on executive compensation and shareholder meeting matters.

Filing Documents

• qure-20240618xdef14a.htm (DEF 14A) — 2050KB
• qure-20240618xdef14a_a006.jpg (GRAPHIC) — 10KB
• qure-20240618xdef14a_a009.jpg (GRAPHIC) — 20KB
• qure-20240618xdef14a_a015.jpg (GRAPHIC) — 63KB
• qure-20240618xdef14a_a016.jpg (GRAPHIC) — 64KB
• qure-20240618xdef14a_bg001.jpg (GRAPHIC) — 200KB
• qure-20240618xdef14a_bg002.jpg (GRAPHIC) — 135KB
• 0001558370-24-005525.txt (&nbsp;) — 4105KB
• qure-20240618.xsd (EX-101.SCH) — 5KB
• qure-20240618_def.xml (EX-101.DEF) — 6KB
• qure-20240618_lab.xml (EX-101.LAB) — 12KB
• qure-20240618_pre.xml (EX-101.PRE) — 6KB
• qure-20240618xdef14a_htm.xml (XML) — 229KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 44 17. COMPENSATION COMMITTEE REPORT 47 18. COMPENSATION DISCUSSION & ANALYSIS 48 19. SUMMARY COMPENSATION TABLE 69 20. OUTSTANDING EQUITY AWARDS AT FISCAL YEAR END 2023 71 21. GRANTS OF PLAN-BASED AWARDS FOR 2023 73 22. OPTION EXERCISES AND STOCK VESTED IN 2023 75 23. DIRECTOR COMPENSATION 86 24. DIRECTOR COMPENSATION TABLE 87 25. GENERAL MATTERS 88 26. APPENDIX A 90 27. APPENDIX B 91 Table of Contents NOTE REGARDING FORWARD-LOOKING STATEMENTS Certain statements in the following Proxy Statement for the 2024 Annual General Meeting of Shareholders are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the " Exchange Act ") are subject to the safe harbor created by those sections. Forward-looking statements are based on our current assumptions, projections and expectations of future events, and are generally identified by words such as "may," "will," "should," "could," "would," "expects," "plans," "anticipates," "believes," "estimates," "projects," "predicts," "potential" and similar expressions, or the negatives thereof, or future dates. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected or implied. The most significant factors known to us that could materially adversely affect our business, operations, industry, financial position or future financial performance are described in "Part I, Item 1A, Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the " Annual Report ") filed with the Securities and Exchange Commission (the " SEC ") on February 28, 2024. You should not place undue reliance on any forward-looking statement, which speaks only as of the date made, and should recognize that forward-looking

View Full Filing

View this DEF 14A filing on SEC EDGAR